SINGAPORE, July 8, 2022 /PRNewswire/ — iGene Laboratory, the molecular diagnostics laboratory subsidiary of INEX Innovate Pte Ltd, announces the launch of its research-use-only (RUO) polymerase chain reaction (PCR) Monkeypox test in response to the recent outbreak of the virus.
The Monkeypox virus predominately occurs in Central and Western Africa, that causes a disease with symptoms similar to Smallpox – fever, headache, swollen lymph nodes, fatigue, and muscle aches along with characteristic pox lesions. Monkeypox is a zoonosis: a disease that is primarily transmitted from animals to humans, although human to human transmission can also occur. It can be transmitted through contact with bodily fluids, lesions on the skin or on internal mucosal surfaces, such as in the mouth or throat, respiratory droplets and contaminated objects. Detection of viral DNA by polymerase chain reaction (PCR) is the preferred laboratory test for Monkeypox. The best diagnostic specimens are directly from the rash – skin, fluid or crusts, or biopsy where feasible. The incubation period for onset of symptoms can be between 5-21 days with 6-13 days being the average. Symptoms can last from 2-4 weeks.[1]
The World in Data reports 3339 cases on 22ndJune 2022. As of 5 July there were 7075 cases, representing a 107% increase in two weeks.[2]
In Singapore, there are now three confirmed cases including two imported cases and one local case.[3]
The iGene (RUO) Monkeypox PCR test targets two specific conservative regions of the Monkeypox virus in addition to an internal control by the use of real-time PCR. Real-time PCR is the same methodology used by iGene Laboratory for the detection of COVID-19. This test is available only for research use, and provides results within 4 hours of sample processing.
iGene Laboratory Chief Executive Kane Black said “In another first iGene Lab has launched a RUO Monkeypox PCR test in response to the recent outbreak of the virus in non-endemic countries. The launch of the Monkeypox test further augments the company’s PCR infectious disease portfolio and strengthens the company’s position as a leader in the field.”
1. WHO. (2022). Monkeypox. https://www.who.int/news-room/fact-sheets/detail/monkeypox
2. Edouard Mathieu, Saloni Dattani, Hannah Ritchie and Max Roser (2022) – “Monkeypox”. Published online at OurWorldInData.org. Retrieved from: ‘https://ourworldindata.org/monkeypox‘ [Online Resource]3. Channel News Asia (CNA). 6 June 2022.Singapore confirms first local case of monkeypox infection. https://www.channelnewsasia.com/singapore/monkeypox-singapore-first-local-case-2792906
Donate To The Indian Sun
Dear Reader,The Indian Sun is an independent organisation committed to community journalism. We have, through the years, been able to reach a wide audience especially with the growth of social media, where we also have a strong presence. With platforms such as YouTube videos, we have been able to engage in different forms of storytelling. However, the past few years, like many media organisations around the world, it has not been an easy path. We have a greater challenge. We believe community journalism is very important for a multicultural country like Australia. We’re not able to do everything, but we aim for some of the most interesting stories and journalism of quality. We call upon readers like you to support us and make any contribution. Do make a DONATION NOW so we can continue with the volume and quality journalism that we are able to practice.
Thank you for your support.
Best wishes,
Team The Indian Sun
